Measuring Anticipated Attitudes and Behavior Towards a New Medical Treatment in Lesotho (NCT06246058) | Clinical Trial Compass
CompletedNot Applicable
Measuring Anticipated Attitudes and Behavior Towards a New Medical Treatment in Lesotho
Lesotho475 participantsStarted 2024-02-15
Plain-language summary
The primary research objective is to examine how uncertainty towards a new medical treatment changes in patients when a partner (can be any close other, i.e. romantic partner, family member, or a close friend) supports the new treatment choice and is willing to be involved in the patient's treatment. I hypothesize that when the patients know that their partner supports uptake of the new medical treatment and will physically accompany them to the visit, patients will (1) experience lower levels of uncertainty and (2) report a higher likelihood of participating in a new treatment in the future, as compared to patients who face the decision about the new treatment alone.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults over 18 years of age
* Are comfortable reading and writing in Sesotho or English
* Attending as a patient in Butha Buthe-area hospital or health center for a known clinical diagnosis or standard health screening related to one of these illness categories:
* HIV
* Other sexually-transmitted infection (i.e. gonorrhea, syphilis, hepatitis)
* Breathing problem/ tuberculosis
* Heart issues/ blood pressure
* Diabetes/ sugar level
* Bone/ muscle problem
* Mental health
* Memory/ thinking problem
* Teeth/ mouth problem
* Cancer
* Maternal health (i.e. pregnancy, post-partum care)
Exclusion Criteria:
* Have participated in this study before
* Visible intoxication and/or distress, as deemed by trained research assistant
* Unable to make independent decisions; unable to complete informed consent
* Warrants emergency medical care
* Visiting the hospital for another person (i.e. their child, relative, partner)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
AA-Med score
Timeframe: 1 time measurement immediately after intervention